Delivery Order SPE2DB22D1106-SPE2DB25FERH9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,817.86 to AmerisourceBergen Drug Corp for Motegrity 2 mg tablets (30-count units) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was...
- The Defense Logistics Agency awarded a delivery order valued at $3,462.33 to AmerisourceBergen Drug Corp for Motegrity 2 mg tablets (30-count units) on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price contract was placed with no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Motegrity 2 mg tablets (30-count units) with a ceiling value of $1,404.42 under a firm fixed-price arrangement. The contract, awarded on August 28, 2025, with an ultimate completion date of August 29, 2025, represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and primary...
- The Defense Logistics Agency awarded a delivery order valued at $4,228.58 to AmerisourceBergen Drug Corp for the supply of Motegrity 1 mg tablets (30-count unit doses) with a firm fixed price and completion deadline of September 29, 2025. This competitive, non-set-aside contract was executed on September 26, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,813.38 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Motegrity 2 mg tablets in quantities of 30 units. This is a firm fixed price, non-set-aside contract with performance completed by July 15, 2025, and fulfillment based at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of the prescription medication Motegrity 2 mg tablet. The $1,309.29 firm fixed-price contract has a performance period through May 20, 2025 and is not set aside for any specific business type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00. This IDC, designated as...
- This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Motegrity 2 mg tablets to the Defense Medical Logistics Standard Support (DMLSS) program. The $4,891.22 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 9, 2021. The contract has a completion date of September 10, 2021 and was not designated with a set-aside. AmerisourceBergen Drug Corp is a subsidiary of the parent company...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,308.80 firm fixed-price delivery order is for the medication Motegrity 2 mg tablets. The contract has an ultimate completion date of July 25, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This contract award from the Defense Logistics Agency (DLA) is for the delivery of Motegrity 2 mg tablets to the federal government. The $3,096.63 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with no set-aside designation. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and...
- This is a delivery order contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,901.65, is for the supply of Motegrity 2 mg tablets to support federal healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FERH9Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Motegrity 2 mg tablets (30-count units) with a ceiling value of $1,657.97. This competitively awarded, firm fixed-price delivery order was issued on June 3, 2025, with an ultimate completion date of June 4, 2025. The contract is being performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, and carries no set-aside designation. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, AmerisourceBergen fulfills critical medical procurement needs across multiple therapeutic domains, including specialty medications, generic drugs, and medical supplies supporting military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 6/3/25 |